Skip to main content
. 2021 May 18;22(5):496–503. doi: 10.1089/sur.2020.166

Table 4.

Patient-Centered Outcomes by Mesh Type

  Biologic mesh n = 33 Synthetic mesh n = 36a Mean difference (95% CI)b p
AW-QOL Scores (mAAS), mean (SD)
 Baseline 42.3 (29.9) 42.1 (30.5)
 Follow-up 62.6 (27.4) 70.0 (28.1) −7.4 (−20.8 to 6.0) 0.273
 Change 20.3 (31.2) 27.9 (31.3) −7.6 (−22.6 to 7.4) 0.316
 ANCOVA −7.5 (−19.7 to 4.7) 0.226
AW-QOL change category, No (%)
 Worsened (<7) 5 (15.1%) 4 (11.1%) 1.36 (0.40–4.65)c 0.747
 Improved (>7) 22 (66.7%) 27 (75.0%) 0.89 (0.65–1.21)c
 No change 6 (18.2%) 5 (13.9%) 1.31 (0.44–3.89)c
Pain scores (VAS), mean (SD)
 Baseline 6.2 (3.4) 7.2 (2.9)
 Follow-up 4.3 (3.3) 4.0 (3.5) 0.3 (−1.3 to 2.0) 0.687
 Change −1.8 (4.1) −3.2 (3.5) −1.4 (−3.2 to 0.49) 0.148
 ANCOVA 0.8 (−0.9 to 2.3) 0.382

AW-QOL = Abdominal wall quality of life; mAAS = Modified Activity Assessment Scale (range from 1 = poor to 100 = perfect, minimally clinically important difference [MCID] = 7), VAS = visual analog scale (range from 0 = no pain to 10 = worst possible pain, MCID = 1); SD = standard deviation; ANCOVA = analysis of covariance.

a

One patient did not complete the one-year post-operative survey.

b

Synthetic mesh represents the control for mean difference calculation.

c

Relative risk is reported instead of difference in median as variable is categorical.